Bulevirtide Beneficial in Hepatitis D: Phase 3 Data

“For us in the hepatitis D field, it is a really exciting time; it’s completely novel data and game-changing for patients.”
Medscape Medical News

source https://www.medscape.com/viewarticle/976612?src=rss